Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.70 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.70 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.70 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.70 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.66 |
| ▸ | GAA | P10253 | 6/20 | 0.66 |
| ▸ | MAPT | P10636 | 5/20 | 0.66 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.66 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.59 |
| ▸ | GLA | P06280 | 1/20 | 0.59 |
| ▸ | HPGD | P15428 | 1/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.57 |
| ▸ | PTPN22 | Q9Y2R2 | 1/20 | 0.54 |
| ▸ | CRHBP | P24387 | 1/20 | 0.53 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.51 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.51 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29357214 | 0.83 | HSD17B10 (1.00) | HSD17B10CYP1A2CYP2C9CYP2C19KDM4E | |
| SCHEMBL36762 | 0.83 | HSD17B10 (1.00) | HSD17B10CYP1A2CYP2C9CYP2C19KDM4E | |
| SCHEMBL226196 | 0.83 | HSD17B10 (0.76) | HSD17B10CYP1A2CYP2C9CYP2C19KDM4E | |
| SCHEMBL761745 | 0.81 | HSD17B10 (0.73) | HSD17B10CYP1A2CYP2C9CYP2C19KDM4E | |
| SCHEMBL4019720 | 0.79 | HSD17B10 (0.70) | HSD17B10CYP1A2CYP2C9CYP2C19KDM4E | |
| SCHEMBL3361843 | 0.79 | HSD17B10 (0.70) | HSD17B10CYP1A2CYP2C9CYP2C19KDM4E | |
| SCHEMBL17799782 | 0.79 | HSD17B10 (0.70) | HSD17B10CYP1A2CYP2C9CYP2C19KDM4E | |
| SCHEMBL11660676 | 0.79 | HSD17B10 (0.70) | HSD17B10CYP1A2CYP2C9CYP2C19KDM4E | |
| SCHEMBL2452503 | 0.79 | KDM4E (1.00) | HSD17B10CYP1A2CYP2C9CYP2C19KDM4E | |
| SCHEMBL13369633 | 0.79 | HSD17B10 (0.70) | HSD17B10CYP1A2CYP2C9CYP2C19KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101786934-B | Preparation method of aromatic formaldehyde | UNIV JIANGXI NORMAL SCI & TECH | 2012-10-10 | — | — | CN | disclosed |
| CN-101786934-A | Preparation method of aromatic formaldehyde | JIANGXI NORMAL UNIVERSITY OF S | 2010-07-28 | — | — | CN | disclosed |
| US-7582660-B2 | 2-thio-substituted imidazole derivatives and their use in pharmaceutics | C-A-I-R BIOSCIENCES GMBH (DE) | 2009-09-01 | — | — | US | disclosed |
| US-20060235054-A1 | 2-Thio-substituted imidazole derivatives and their use in pharmaceutics | MERCKLE-GMBH (DE) | 2006-10-19 | — | — | US | disclosed |
| EP-1539741-A1 | 2-THIO-SUBSTITUTED IMIDAZOLE DERIVATIVES AND THEIR USE IN PHARMACEUTICS | MERCKLE GMBH (DE) | 2005-06-15 | — | — | EP | disclosed |
| WO-2004018458-A1 | 2-THIO-SUBSTITUTED IMIDAZOLE DERIVATIVES AND THEIR USE IN PHARMACEUTICS | MERCKLE-GMBH (DE) | 2004-03-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060235054-A1 | 2-Thio-substituted imidazole derivatives and their use in pharmaceutics | IL2, TPMT, IFNG | HSD17B10 2580/4885CYP1A2 64/4885CYP2C9 161/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.